The NASA research group develops a targeted mitochondrial replacement therapy that transplants undamaged mitochondria isolated preflight into human cells. By supplementing damaged organelles, the approach restores cellular energetics after radiation exposure and counteracts age-related mitochondrial dysfunction, potentially extending healthy lifespan and mitigating cardiovascular and neurodegenerative diseases.
Key points
NASA’s STMD-funded project harvests autologous healthy mitochondria and transplants them to counteract radiation and aging damage.
Extracellular vesicles deliver mitochondria to restore ATP production and reduce oxidative stress in human cell models.
In vitro studies inform dosage, timing, and system design for deep space missions and broader anti-aging applications.
Why it matters:
This therapy offers a novel avenue to prevent radiation-induced damage and treat age-related diseases by replenishing mitochondrial function globally.
Q&A
What role do mitochondria play in cells?
How does mitochondrial replacement therapy work?
Why is this therapy important for astronauts?
What challenges must be overcome for clinical use?
Read full article
Academy
Mitochondria and Their Role in Aging
Introduction: Mitochondria are often described as the powerhouses of the cell because they generate adenosine triphosphate (ATP), the main energy currency. Each cell can contain hundreds or thousands of mitochondria, which convert nutrients into ATP through oxidative phosphorylation. Aside from energy production, mitochondria regulate calcium levels, programmed cell death (apoptosis), and other metabolic pathways. Healthy mitochondrial function is essential for tissue maintenance, repair, and overall organismal health. As organisms age, mitochondria can sustain damage from reactive oxygen species (ROS), accumulate mutations in mitochondrial DNA, and become less efficient at producing ATP. This decline contributes to reduced cellular repair, increased oxidative stress, and progression of age-related diseases such as neurodegeneration, cardiovascular dysfunction, and metabolic disorders.
Mitochondrial Dysfunction and Longevity Science
Mitochondrial dysfunction is a hallmark of aging. Research in longevity science has shown that restoring or maintaining mitochondrial health can influence the aging process. Models in worms, flies, and mice demonstrate that interventions such as caloric restriction, exercise, and certain compounds can improve mitochondrial performance. Cellular studies reveal that damaged mitochondria release ROS that damage proteins, lipids, and DNA, triggering inflammation and cell death. The gradual accumulation of malfunctioning mitochondria impairs tissue function over time. Approaches that stimulate mitochondrial biogenesis (creation of new mitochondria) or enhance quality control pathways, such as mitophagy (selective removal of damaged mitochondria), are under investigation to promote healthy lifespan. Understanding these mechanisms is critical for developing therapies that address the root causes of cellular aging.
Mitochondrial Replacement Therapy
Principle: Mitochondrial replacement therapy (MRT) involves harvesting healthy mitochondria, typically from young cell cultures or donor tissues, and introducing them into cells with compromised mitochondrial populations. The goal is to replace aged or damaged mitochondria with fresh organelles to restore cellular energetics.
- Harvesting and Isolation: Cells such as fibroblasts or muscle biopsies provide a source of functional mitochondria. These organelles can be extracted through gentle mechanical disruption and differential centrifugation, followed by purification steps.
- Packaging and Delivery: Isolated mitochondria are often encapsulated in extracellular vesicles or specialized buffers to protect them during transfer. Delivery methods include direct injection into tissues, perfusion in isolated cell cultures, or incorporation into biocompatible gels for localized treatment.
- Cellular Uptake and Integration: Recipient cells endocytose the mitochondria or take them up via membrane fusion. Once inside, the new mitochondria integrate into the existing network, producing ATP and reducing ROS levels. The success of engraftment depends on compatibility between the mitochondrial and nuclear genomes.
- Therapeutic Applications: Initially studied for preventing inherited mitochondrial diseases in embryos (germline MRT), current research focuses on somatic mitochondrial transplantation to treat acute injuries, ischemia-reperfusion damage, neurodegeneration, and, as highlighted by NASA, radiation-induced cell damage in astronauts.
Challenges and Future Directions: Scaling MRT for widespread clinical use requires developing standardized isolation protocols, ensuring long-term viability of mitochondria, avoiding immune responses, and establishing regulatory frameworks. Ongoing research aims to optimize delivery vehicles, improve engraftment efficiency, and monitor mitochondrial dynamics after transplantation. As these methods advance, MRT holds promise for extending healthy lifespan by addressing a fundamental driver of cellular aging.
By integrating MRT into broader longevity strategies such as exercise, diet, and pharmacological interventions, researchers aim to achieve synergistic improvements in healthspan and organismal resilience.